The balance between vasoconstrictor and vasodilator mediators, such as nitric oxide (NO), prostacyclin (PGI2), and endothelin-1 (ET-1), regulates vascular tone, and a shift toward vasoconstriction is associated with hypertension progression [184]. This evidence concerns the gene EDN1 and hypertensive disorder.